drugset
drugset / Trial / NCT02595268

A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants

NCT02595268 ↗

Phase 1 Completed 14 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-label

Summary

The purpose of this study is to evaluate the effect of steady-state concentrations of JNJ-63623872 on the single-dose pharmacokinetics of pitavastatin in healthy participants.

Timeline

Start
2015-11
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimodivir Small molecule 600 mg Oral
Subject Pitavastatin Small molecule 1 mg Oral

Indications

No indication recorded.